Funding announcement of Dectrocel Healthcare and Research (SISFS)

StartupFundingCounter 09/2022/AICBIMTECH


Atal Incubation Centre- BIMTECH is delighted to announce investments in Dectrocel Healthcare and Research under Startup India Seed Fund Scheme #SISFS. 


Dectrocel provides an automated end-to-end solution for personalized diagnostics, producing real-time patient diagnostics reports, within a few hours that give unique clinical insights on individual patients’ health conditions and help facilitate personalized medicine.


We wish Dr. Ankit Shukla, Founder, Ms. Saumya Shukla, Co-Founder & CEO, and Mr. Nikhil Misra, CTO, and the entire Dectrocel team the best of luck in their future endeavors and look forward to seeing Dectrocel make a name for themselves in the Healthcare industry.


Visit Dectrocel at –

Join our cohort, KHOJ 8.0 –


1 thought on “Funding Announcement of Dectrocel Healthcare and Research – Startup India Seed Fund Scheme (SISFS)”

  1. aicadmin

    Prof A K Shukla has been a key investigator in our quest at Agra to develop radiotargetted therapy in solid cancers., and currently has helped the S N Medical College, Agra in the design of the new Nuclear Medicine Unit being built there , to work with the Cancer Unit.
    Earlier it was a pleasure to interact with him when he wrote his PhD thesis, with us prior to joining the SGPGI at Lucknow. He was involved both in our experimental animal as well as clinical work. He is keenly interested in Research! I am confident that at Dectrocel he will play a major role in nursing new research ventures.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top